- Home
- BLDE vs CADL Comparison
BLDE vs CADL Comparison
Compare BLDE & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDE
- CADL
- Stock Information
- Founded
- BLDE 2014
- CADL 1999
- Country
- BLDE United States
- CADL United States
- Employees
- BLDE N/A
- CADL N/A
- Industry
- BLDE Aerospace
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- BLDE Consumer Discretionary
- CADL Health Care
- Exchange
- BLDE Nasdaq
- CADL Nasdaq
- Market Cap
- BLDE 276.7M
- CADL 306.4M
- IPO Year
- BLDE N/A
- CADL 2021
- Fundamental
- Price
- BLDE $3.56
- CADL $11.63
- Analyst Decision
- BLDE Buy
- CADL Strong Buy
- Analyst Count
- BLDE 1
- CADL 4
- Target Price
- BLDE $6.00
- CADL $19.75
- AVG Volume (30 Days)
- BLDE 547.8K
- CADL 1.2M
- Earning Date
- BLDE 03-11-2025
- CADL 03-27-2025
- Dividend Yield
- BLDE N/A
- CADL N/A
- EPS Growth
- BLDE N/A
- CADL N/A
- EPS
- BLDE N/A
- CADL N/A
- Revenue
- BLDE $241,814,000.00
- CADL N/A
- Revenue This Year
- BLDE $11.00
- CADL N/A
- Revenue Next Year
- BLDE $5.14
- CADL N/A
- P/E Ratio
- BLDE N/A
- CADL N/A
- Revenue Growth
- BLDE 12.04
- CADL N/A
- 52 Week Low
- BLDE $2.45
- CADL $1.34
- 52 Week High
- BLDE $5.17
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- BLDE 40.62
- CADL 72.95
- Support Level
- BLDE $3.35
- CADL $8.11
- Resistance Level
- BLDE $4.05
- CADL $13.68
- Average True Range (ATR)
- BLDE 0.23
- CADL 0.78
- MACD
- BLDE -0.00
- CADL 0.42
- Stochastic Oscillator
- BLDE 29.17
- CADL 70.29
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.